An aminophenothiazine inhibitor of the NCS-1/Ric8a complex regulates synaptic function in fragile X syndrome
María José Sánchez-Barrena(Consejo Superior de Investigaciones Científicas), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Alberto Ferrús(Consejo Superior de Investigaciones Científicas), Loreto Martínez‐González(Consejo Superior de Investigaciones Científicas), Nuria E. Campillo(Centro de Investigaciones Biológicas Margarita Salas), Alicia Mansilla(Universidad de Alcalá), Efthimios M. C. Skoulakis(Alexander Fleming Biomedical Sciences Research Center), Ουρανία Σεμελίδου(Alexander Fleming Biomedical Sciences Research Center), Antonio Chaves-Sanjuán(Consejo Superior de Investigaciones Científicas)
Cited by 0
Related Papers
Monoclonal antibodies against the Drosophila nervous system.
|Proceedings of the National Academy of Sciences|1982|534
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
Shaker encodes a family of putative potassium channel proteins in the nervous system of Drosophila.
|The EMBO Journal|1988|445
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348